BACKGROUND AND PURPOSE: Clival invasion, a rare but potentially significant complication of pituitary adenoma, is difficult to detect on MR imaging. Because CT is widely used in adjunct guidance of pituitary surgery and it has recently been suggested that preoperative CT may add useful diagnostic information in addition to pituitary MR imaging, we performed the first large cross-sectional imaging study to define the image attributes, clinical correlates, and prognostic implications of clival invasion on CT for pituitary adenoma surgical guidance.
rhinorrhea and other complications. The portion of the clivus invaded by pituitary adenomas is most commonly in the anterior/cephalad portion, derived developmentally from the basisphenoid bone. Because of its exquisite soft-tissue contrast for evaluation of sellar tumors, their suprasellar extension, parasellar cavernous sinus invasion, and dural invasion, MR imaging is the primary technique for preoperative assessment of pituitary adenoma and guidance of resection. In many centers, CT is used as an adjunct for guidance because of its superior depiction of bony anatomy, but though it has recently been reported to add useful information to pituitary MR imaging in depicting erosion of the sellar floor and clivus, it is not generally regarded as providing significant diagnostic information. 3 Our clinical experience with guidance CT suggested that the superior depiction of bony anatomy on CT provides a highly sensitive examination for clival invasion by adenoma, which is often difficult to detect on MR imaging, we designed a retrospective study to assess the performance of CT for operative guidance in 390 patients with pathologically confirmed pituitary macroadenoma. Our analysis was designed to determine the frequency of clival invasion and the association of CT-detected invasion with patients' clinical factors, surgical outcomes, and tumor subtypes.
Materials and Methods

Patient Demographics and Exclusion Criteria
The local institutional ethics committee approved this study and granted a waiver of informed consent. CT and clinical data were retrieved retrospectively for 498 consecutive patients who underwent pituitary surgery at a leading Chinese neurosurgical hospital between September 2008 and April 2009 and whose tumors fulfilled the WHO histopathologic 2007 criteria for the diagnosis of pituitary adenoma. 4 One hundred eight patients (22%) were excluded on the basis of the following criteria: 1) absence of preoperative CT scanning (55 patients), 2) preoperative CT scans lacking MPR (24 patients), 3) pituitary microadenoma (15 patients), 4) recurrent pituitary adenoma following prior resection at other institutions (8 patients), and 5) preoperative radiation therapy (6 patients). Three hundred ninety patients (208 men, 182 women; mean age, 45.78 Ϯ 12.53 years, range, 18 -75 years) were included in further analysis.
Image Acquisition
All patients included in this study had undergone preoperative CT of the sella turcica with a standard institutional protocol for assessment of bone invasion within 2 weeks before surgery. Patients were scanned on a 16-section CT scanner (Somatom Sensation; Siemens, Erlangen, Germany) in the supine position. The scanner gantry was angled parallel to a line connecting the outer canthus of the eye to the external auditory meatus (canthomeatal line), and imaging was performed from the superior margin of the odontoid process to the level of foramen of Monro. The protocol consisted of axial scanning with production of sagittal and coronal MPR. Acquisition parameters were the following: 120 KV; 310 mA; and 0.8-mm collimation. Axial reconstructions with an FOV of 250 mm, matrix of 512 ϫ 512, section thickness and gap of 0.75 mm were produced and used to produce sagittal and coronal MPR. Section thickness varied slightly according to the size of the adenoma, with a thickness of 2-3 mm and gap of 2-4 mm.
Image Analysis
The preoperative CT images were retrospectively and independently analyzed by 2 neuroradiologists (L.A., 13 years of experience, and S.L., 15 years of experience) who were blinded to the patients' histories, physical examination findings, results of serum tests, tumor subtypes, and detection of gross invasion at surgery. Manual measurement of maximal tumor diameters (millimeters) was performed in cephalocaudal, left-right, and anteroposterior directions, by using the scanner console software. For each tumor, the measurement was performed twice and the average value was recorded as the final diameter. The tumor volume (cubic centimeters) was calculated according to the following formula: V lesion ϭ ( / 6) ϫ height ϫ width ϫ length. 5 The volume was classified by median and quartile (25%-75%) values.
Invasion of the clivus was diagnosed when there was a focal or widespread defect in the cortex of the clivus and decreased attenuation in the underlying trabecular bone. When the cortex was continuous and no decrease in underlying trabecular bone attenuation was seen, the process was regarded as bony remodeling and not classified as clival invasion. Clival invasion was classified as focal when the width of the low-attenuation area was less than half of the width of the clivus on the same section or less than one-third of the height of the clivus on sagittal MPR. All others cases of invasion were classified as extensive.
Clinical and Histopathologic Diagnosis
Results of endocrine panel testing performed 1 week before surgery were retrieved. This panel included triiodothyronine, tetraiodothyronine, supersensitive TSH, dissociated triiodothyronine and tetraiodothyronine, PRL, LH, FSH, estradiol, progesterone, GH, ACTH, cortisol hydrocortisone, and testosterone. Routine diagnostic histopathologic analysis including interpretation of standard hematoxylin-eosinϪstained sections was retrieved and used to confirm the diagnosis of pituitary adenoma. Immunohistochemical staining results were retrieved to subclassify the tumors by the presence of secretory granules or precursors for FSH, GH, PRL, ACTH, TSH, or LH. Tumors demonstrating no staining for any of the above hormones or precursors were classified as null-cell adenomas. Otherwise, they were regarded as secreting adenomas.
Statistical Analysis
Statistical analysis was performed on commercial statistical software (Statistical Package for the Social Sciences, Version 10.0; SPSS, Chicago, Illinois). Binary and multinomial logistic regression was used to test the influence of patient age, sex, tumor subtype, and tumor volume on the rates of clival invasion. The 2 test was used to analyze the association of patient sex, pathologic subtype, operative approach and complications, and recurrence with clival invasion. This test was also used to analyze the difference in frequency of null-cell tumors between male and female patients. The 2 independent-samples t test was used to test the difference in follow-up periods between the patients with clival destruction and those without. Because the tumor volume data did not include a normal distribution, the Mann-Whitney U test was used to compare tumor volumes between male and female patients, between null-cell and secreting macroadenomas, between tumors with and without clival invasion, and between tumors with focal and extensive clival invasion. The correlation between tumor volume and pathologic subtypes (null-cell versus secreting tumors) was analyzed by Spearman correlative analysis. A P value Ͻ.05 was considered statistically significant. Table 1 lists that pathologic subtypes of tumors in the 390 patients included in the study and the 108 excluded patients. The percentage of women was not significantly different between the included (47%) and excluded (48%) groups. The included and excluded populations were not different ( 2 ϭ 1.265, P ϭ .261). Thirty-two of 390 patients (8.21%) had invasion of the clivus at surgery ( Table 2 ). All macroadenomas with clival invasion underwent subtotal resection: 26 (81%) by a transsphenoidal approach and 6 (19%) by a transfrontal approach. Of the remaining 358 tumors without clival invasion, 330 (92%) underwent transsphenoidal surgery and 28 (8%), transfrontal surgery. This resulted in 99 (28%) gross total resections and 259 (72%) subtotal resections. Operative complications for the 390 tumors included infarction of the frontal lobe, temporal lobe, and genu of the corpus callosum; intraventricular hemorrhage; subarachnoid hemorrhage; frontal lobe parenchymal hematoma; and cerebrospinal rhinorrhea.
Results
One hundred forty-two of 390 cases (36%) were pathologically classified as null-cell adenomas. Twenty of the 142 nullcell adenomas (14%) showed elevated hormone levels: supersensitive TSH (n ϭ 1), serum PRL (n ϭ 17), both serum PRL and cortisol (n ϭ 1), and both serum PRL and supersensitive TSH (n ϭ 1). Of the 17 patients with null-cell adenomas with elevated serum PRL, 1 female patient showed diffuse clival invasion. Because the conflict between the pathologic subtype and secretory status in these patients rendered their classification equivocal, a subanalysis was performed excluding them. Analysis of the remaining 122 unequivocal null-cell macroadenomas still demonstrated larger size (P ϭ .010) and more frequent clival invasion ( 2 ϭ 22.101, P Ͻ .001) than the 248 secreting adenomas and a female predominance of clival invasion ( 2 ϭ 13.495, P Ͻ .001). Logistic regression analysis) revealed a significant correlation between clival invasion and female sex ( 2 ϭ 13.861, P Ͻ 0.001), large tumor size (P Ͻ 0.001) and null-cell pathologic subtype 2 ϭ 18.937, P Ͻ 0.001 (Tables 2 and 3 ). There was no significant difference between the size of tumors in women (5.73 Ϯ 7.22 cm 3 ) and men (5.92 Ϯ 7.63 cm 3 , P ϭ .174) or between the incidence of pituitary macroadenoma in women and men ( Table 2 ). The correlation between clival invasion and null-cell subtype was slightly strengthened after exclusion of the 20 false null-cell tumors (OR ϭ 5.47; range, 2.45-12.21; P Ͻ .001, binary logistic regression).
Although null-cell macroadenomas were less common in this series than secreting tumors, statistical analysis demonstrated a higher rate of clival invasion in null-cell macroadenomas ( 2 ϭ 18.937, P Ͻ .001; Table 2 ). Null-cell macroadenomas were found in 32% (59/182) of the female patients and 40% (83/208) of the male patients. The difference was not significant ( 2 ϭ 2.350, P ϭ .125). Although the operative approach was similar between patients whose tumors had clival invasion on CT and those whose did not, gross total resection was less frequent and operative complications were significantly more common in patients with clival invasion on CT (16%, 5/32) ( Table 4) . Despite a similar period of follow-up, recurrence was seen in a higher ratio of patients with clival invasion (57%, 8/14) .
Larger tumor volume correlated with higher frequency of clival invasion (Table 3 ). The 32 tumors with clival invasion were significantly larger than those in the 358 patients without invasion ( Table 2 , P Ͻ .001), and 25 tumors with extensive clival invasion (18.90 Ϯ 9.05 cm 3 , Fig 1A, -B) were significantly larger than those in the 7 patients with localized invasion (14.04 Ϯ 3.35 cm 3 , P ϭ .038, Fig. 2A, -B) . In addition, the mean volume of the 142 null-cell macroadenomas (7.69 Ϯ 11.37 cm 3 ) was significantly larger than that of the 248 secreting tumors (4.87 Ϯ 6.59 cm 3 , P ϭ .006). Nevertheless, despite correction for the significant correlation of tumor volume with pathologic subtype (r ϭ Ϫ0.247, P Ͻ .001), an independent correlation persisted between tumor volume and clival invasion (b ϭ Ϫ.050, P Ͻ .001, OR ϭ 0.951).
Discussion
The invasive nature of pituitary macroadenoma is well documented, but while invasion of the cavernous sinuses and carotid arteries and along the dura is common, invasion of the clivus is relatively rare. The few reports published to date have not reported series of sufficient size to establish the characteristic clinical, pathologic, and imaging attributes of clival invasion by pituitary adenoma. [6] [7] [8] [9] In our study population, most patients with macroadenoma presented in the fourth and fifth decades of life; the frequency and size of macroadenoma were nearly equal in men (53.33% of cases; 5.92 Ϯ 7.63 cm 3 ) and women (46.67%; 5.73 Ϯ 7.22 cm 3 ); the proportion of null-cell pituitary macroadenoma was 36.4% (142/390). These population statistics are similar to previous reports, [10] [11] [12] [13] suggesting that this sample, though retrospective, may be a relatively good representation of the general population of patients with adenoma.
Among patients with macroadenoma in this study, female sex was the strongest risk factor for clival invasion (OR ϭ 3.62, P ϭ .014). The multinomial logistic regression also demonstrated a female predominance (P Ͻ .001). This finding came as a surprise because the incidence of macroadenoma and tumor size was similar between women and men in our series and because it is discordant with a previous study suggesting that macroadenomas and invasive adenomas are significantly more frequent in men.
14 The discrepancy with this previous report seems likely to be due to the type of invasion studied. In addition to bone invasion, Qian et al 14 included invasion of the sphenoid sinuses, cavernous sinuses, and brain in their study, whereas we focused exclusively on invasion of the clivus.
Larger tumor volume was the second most important risk factor after female sex (OR ϭ 1.08, P Ͻ .001). When analyzed as a group, the 32 tumors with clival invasion were larger than the 358 tumors without clival invasion (P Ͻ .001), and the 25 tumors with extensive invasion were larger than those in the 7 tumors with localized invasion (P ϭ .038). This relationship parallels reports of increased cavernous sinus invasion in larger tumors. [15] [16] [17] The finding that clival invasion is more frequent in null-cell adenomas (OR, 4.65) even after correction for larger average tumor volume (P Ͻ .001; OR, 0.951) is intriguing. It suggests that the null-cell phenotype is an independent risk factor for clival invasion, raising the possibility that the null-cell phenotype represents a marker for less differentiated and thus more aggressive tumors. Given the significance of the null-cell phenotype as a risk factor, it is important to consider the implications of the 20 patients in this group with apparent conflict between laboratory analysis and pathology. While we cannot be certain, one likely explanation would seem to be that the tumors were heterogeneous and that the failure to detect secretory staining was a result of histologic sampling error, which would imply that these patients had a mixed phenotype. The persistence of this correlation after exclusion of these 20 equivocal patients supports the notion that null cell phenotype is an independent risk factor for clival invasion.
Female sex, the strongest of the 3 identified risk factors for clival invasion, was also independent of both large tumor size and null-cell subtype. This is supported by the observation that male and female patients in our series did not show a significant difference in macroadenoma incidence, tumor volume (P ϭ .174), or percentage of null-cell tumors (P ϭ .125). This finding could imply either that female patients are prone to more aggressive tumors or that some undefined feature of female patient physiology predisposes to clival invasion. Either effect-tumor-or host-related-seems likely to be due to either genetic or hormonal factors and may deserve further investigation with genetics and in vitro tumor cell culture.
Although our study was not designed to investigate the 
